Purchase price of approximately $500 million, subject to adjustment, net proceeds of which will be dedicated to deleveraging Current pro forma run rate EBITDA of the business in 2025 is approximately $40 million DALLAS, October 28, 2025 (BUSINESS WIRE) – Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, announced today it has […] More